- Report
- September 2025
- 250 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,440GBP
- Report
- December 2025
- 371 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 280 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 379 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- February 2025
- 185 Pages
Global
From €3956EUR$4,500USD£3,448GBP
- Report
- August 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- July 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,068GBP
- Report
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,137GBP
- Report
- January 2025
- 95 Pages
Global
From €3500EUR$4,265USD£3,157GBP
- Report
- May 2025
- 134 Pages
Global
From €15819EUR$17,995USD£13,788GBP
- Report
- December 2025
- 50 Pages
Global
From €2330EUR$2,650USD£2,030GBP
- Report
- December 2025
- 50 Pages
Global
From €2330EUR$2,650USD£2,030GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more